Emmes is a leading contract research organization (CRO) that partners with government, private foundation, and commercial clients to develop treatments for diseases and disorders impacting public health. The Company has provided clinical trial services for over 1,000 trials across Phase I-IV in more than 70 countries, and has a particular expertise in biostatistics, offering government and commercial customers unique capabilities in the analysis and management of clinical trial data.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/11/19 | undisclosed |
Behrman Capital | undisclosed |
